Table 4 Serum IL-37 protein levels in the presence or absence of AS clinical characteristics
From: Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity
Clinical characteristics | n | Present median (interquartile range) | n | Absent median (interquartile range) | P-value |
|---|---|---|---|---|---|
Osteoporosis | 24 | 239.970 (386.146 to 107.470) | 22 | 193.888 (93.536 to 294.802) | 0.0263 |
Peptic ulcer | 8 | 236.358 (135.338 to 341.248) | 38 | 214.052 (93.536 to 386.146) | ns |
liver dysfunction | 17 | 225.617 (116.759 to 279.320) | 29 | 213.832 (93.536 to 386.146) | ns |
Intestinal tuberculosis | 1 | 198.814 | 45 | 218.356 (93.536 to 386.146) | ns |
Leukocytosis | 7 | 250.126 (169.398 to 367.568) | 39 | 212.152 (93.536 to 386.146) | ns |
Kidney dysfunction | 11 | 221.896 (107.470 to 386.146) | 35 | 216.685 (93.536 to 341.248) | ns |
polycythemia | 8 | 246.421 (169.398 to 367.568) | 38 | 213.114 (93.536 to 386.146) | ns |
Hyperlipidemia | 1 | 214.296 | 45 | 218.012 (93.536 to 386.146) | ns |
Adult still disease | 1 | 249.905 | 45 | 214.193 (93.536 to 367.568) | ns |